Med BioGene Posts 2009 Loss of $2.1M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostic test developer Med BioGene, which is working toward commercializing its LungExpress Dx test, earned no revenue in 2009 and took a loss on the year of US$2.1 million, the same amount it lost in 2008.

The Vancouver, BC-based company bumped up its R&D spending by 32 percent last year, from $751,000 in 2008 to $989,000 in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.